An overwhelming 60% of FDA citations from FY22 to FY24 centered on Post Market Surveillance, making this an issue that companies cannot afford to take lightly. It is crucial not only for patient safety but also for meeting regulatory standards and ensuring manufacturer accountability.
In this detailed guide, we examine the role of post-market monitoring, explore the regulatory landscape governing it, and provide expert advice on implementing a robust PMS framework including:
To download Post-Market Surveillance, What You Need to Know to Ensure Patient Safety, please complete the following form.
Morbi nec risus vitae velit ullamcorper dapibus sed sit amet purus. Fusce fringilla euismod libero, non ornare nulla ornare vel. Maecenas ultrices diam suscipit purus molestie imperdiet. Etiam dignissim sagittis bibendum.
Etiam volutpat luctus nibh, non accumsan erat pellentesque a. Quisque enim lacus, varius in dapibus in, lobortis sit amet turpis. Cras nec lobortis quam. Sed eget vestibulum mauris. Fusce consequat neque tellus, et laoreet massa vehicula vitae.
Proin tincidunt velit sit amet aliquet faucibus. Sed auctor vulputate nisl vel auctor. Cras rutrum orci ac lectus porttitor rhoncus. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas.
Duis tempus lorem ornare lacus cursus, eu semper nisl congue. Praesent nulla erat, egestas ac ex non, egestas porttitor nibh. Pellentesque mollis sapien vel mauris malesuada scelerisque. Aenean tincidunt sapien a orci vulputate, in eleifend tellus consequat. Sed finibus, sem in laoreet feugiat, odio ante aliquet leo, suscipit luctus sapien nisl sit amet nunc.